We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics

News   Nov 24, 2016

 
Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics
 
 
 

RELATED ARTICLES

Blood Test May Enable Tailored Cystic Fibrosis Treatment

News

Study used blood test to identify distinct molecular signatures of disease; paves the way to precision medicine for cystic fibrosis.

READ MORE

Statins Have Low Risk of Side Effects

News

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.

READ MORE

Predicting Leaky Heart Valves with 3D Printing

News

A novel 3D printing workflow allows cardiologists to evaluate how different valve sizes will interact with each patient’s unique anatomy, before the medical procedure is actually performed.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE